A multi-institutional research initiative, co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart…
Read More

A multi-institutional research initiative, co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart…
Read More
The pharmaceutical landscape of the 2020s has been defined by the meteoric rise of GLP-1 receptor agonists. Drugs such as…
Read More
The United States Food and Drug Administration (FDA) has granted priority review to a supplemental biologics license application (sBLA) from…
Read More
The rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally altered the landscape of metabolic medicine in the United States.…
Read More
In a landmark study that challenges long-held medical dogmas regarding the permanent nature of cardiac damage, a multidisciplinary research team…
Read More
As the prevalence of glucagon-like peptide-1 (GLP-1) receptor agonists continues to reshape the landscape of metabolic health in the United…
Read More
A collaborative international research effort led by physician-scientists at the University of Arizona College of Medicine – Tucson’s Sarver Heart…
Read More
The rapid rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally altered the landscape of metabolic medicine, offering unprecedented efficacy…
Read More
The fundamental mechanics of animal movement have long been attributed to the microscopic interactions of proteins, but a groundbreaking study…
Read More
In a groundbreaking study that could redefine the landscape of regenerative medicine, researchers at the University of Houston (UH) College…
Read More